Stock search

Ticker or company name

CME card

CME price forecast

CME Group$319,37

P/E now is 26,2. Average over 5 years: 25,2 (range 24–26). The stock is 4% above its history.

Base · FY2030

$349,21+3,8% a year

The base case gives 3,8% a year, below your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$6,91 bn$7,32 bn$7,76 bn$8,22 bn$8,71 bn
Net income$3,97 bn$4,21 bn$4,46 bn$4,73 bn$5,01 bn
EPS$11,02$11,66$12,35$13,07$13,83

Changed values are highlighted. Bear and bull cases: growth ∓ 6%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $319,37

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$237,51

Price change
−25,6%
A year
−5,2%
Fair value today
$172,70
Margin of safety
−45,9%

Base$349,21

Price change
+9,3%
A year
+3,8%
Fair value today
$251,42
Margin of safety
−21,3%

Bull$490,46

Price change
+53,6%
A year
+12,5%
Fair value today
$350,80
Margin of safety
+9,8%

What growth the price implies

For the stock to return 10% a year, revenue must grow 12,6% a year to FY2030 at a 57,5% margin and P/E 25,2.

Growth over 5 years
6%
Analyst consensus
no data
In your model
6%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$349,21+3,8% a year